Breaking News Instant updates and real-time market news.

2022-05-03 06:15:04 HLT Hilton $155.63 / +0.54 (+0.35%) 06:15 05/03/22 05/03 06:15 05/03/22 06:15	Hilton sees Q2 adjusted EPS 98c-$1.03, consensus $1.07 Q2 system-wide comparable RevPAR, on a currency neutral basis, is expected to increase between 45.0 percent and 50.0 percent compared to the second quarter of 2021, and to be down between 5.0 percent to 10.0 percent from the second quarter of 2019.	03 May 20 May

2022-05-03 06:15:04

HLT

Hilton

$155.63 / +0.54 (+0.35%)

06:15

05/03/22

05/03

06:15

05/03/22

06:15

Hilton sees Q2 adjusted EPS 98c-$1.03, consensus $1.07

Q2 system-wide comparable RevPAR, on a currency neutral basis, is expected to increase between 45.0 percent and 50.0 percent compared to the second quarter of 2021, and to be down between 5.0 percent to 10.0 percent from the second quarter of 2019.

03
May
20
May

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks	Agrify enters New Zealand cannabis market with $1.625M Ora Pharm pact » 07:19 06/27/22 06/27 07:19 06/27/22 07:19 AGFY Agrify $2.22 / +0.12 (+5.71%) Agrify announced it has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly AGFY Agrify $2.22 / +0.12 (+5.71%) 06/01/22 Agrify announces launch of CannaBeast 13 short path 05/25/22 Agrify reminds stockholders to vote before proxy voting deadline 05/10/22 Agrify announces multimillion dollar engagement with Boone Labs 05/10/22 Agrify announces multimillion dollar engagement with Boone Labs AGFY Agrify $2.22 / +0.12 (+5.71%) 05/12/22 Alliance Global Partners Agrify price target lowered to $11 from $15 at Alliance Global Partners 03/25/22 Alliance Global Partners Agrify price target lowered to $15 from $32 at Alliance Global Partners 03/24/22 Maxim Agrify price target lowered to $12 from $40 at Maxim 03/23/22 Craig-Hallum Agrify downgraded to Hold at Craig-Hallum on covenant tripping risk AGFY Agrify $2.22 / +0.12 (+5.71%) 05/11/22 Agrify reports Q1 EPS (36c), consensus (33c) 03/23/22 Agrify sees FY22 revenue $140M-$142M, consensus $144.28M 03/23/22 Agrify reports Q4 EPS (60c), consensus (31c) 01/20/22 Agrify reaffirms Q4 revenue guidance of $26M-$28M, consensus $27.84M AGFY Agrify $2.22 / +0.12 (+5.71%) 03/23/22 Fly Intel: Pre-market Movers
Recommendations	Okta not seeing backlash from security breach, says William Blair » 07:18 06/27/22 06/27 07:18 06/27/22 07:18 OKTA Okta $101.20 / +7.8099 (+8.36%) , MSFT Microsoft $267.85 / +8.84 (+3.41%) William Blair analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options OKTA MSFT OKTA Okta $101.20 / +7.8099 (+8.36%) 06/02/22 Okta jumps 16% to $108.35 after raising fiscal year outlook 04/20/22 Okta says January breach lasted 25 minutes, impacted two customers 03/25/22 Okta does not consider January cyber incident 'to be material' 03/22/22 Microsoft says Lapsus$ stole source code through 'limited' access MSFT Microsoft $267.85 / +8.84 (+3.41%) 06/24/22 Ralph Lauren announces nomination of Cupp to board of directors 06/16/22 Square Enix says 'Final Fantasy 7 Rebirth' out next winter for PS5 06/16/22 Microsoft introduces Microsoft Defender for individuals 06/15/22 AvePoint adds Microsoft Azure backup to enhance data protection capabilities OKTA MSFT OKTA Okta $101.20 / +7.8099 (+8.36%) 06/03/22 Morgan Stanley Okta Q1 report should be 'clearing event,' says Morgan Stanley 06/03/22 DA Davidson Okta price target raised to $140 from $125 at DA Davidson 06/03/22 Oppenheimer Okta price target lowered to $170 from $210 at Oppenheimer 06/03/22 BTIG Okta price target lowered to $152 from $216 at BTIG MSFT Microsoft $267.85 / +8.84 (+3.41%) 06/24/22 Citi Citi names top software picks with sector de-rating 'mostly done' 06/17/22 Morgan Stanley Microsoft gaming build out hitting 'overdrive,' says Morgan Stanley 06/16/22 Credit Suisse Credit Suisse says Microsoft Azure growth opportunity not reflected in estimates 06/13/22 Jefferies Microsoft price target lowered to $320 from $325 at Jefferies OKTA MSFT OKTA Okta $101.20 / +7.8099 (+8.36%) 06/02/22 Okta raises FY23 adjusted EPS view to ($1.14)-($1.11), consensus ($1.25) 06/02/22 Okta sees Q2 adjusted EPS (32c)-(31c), consensus (33c) 06/02/22 Okta reports Q1 adjusted EPS (27c), consensus (34c) 06/02/22 Notable companies reporting after market close MSFT Microsoft $267.85 / +8.84 (+3.41%) 06/02/22 Microsoft lowers Q4 EPS view to $2.24-$2.32 from $2.28-$2.35, consensus $2.33 04/26/22 Microsoft sees Q4 productivity and business processes revenue $16.65B-$16.9B 04/26/22 Microsoft reports Q3 EPS $2.22 consensus $2.18 04/26/22 Notable companies reporting after market close OKTA MSFT OKTA Okta $101.20 / +7.8099 (+8.36%) 03/29/22 Okta slow to respond to Lapsus$ Hack, leaked details show, Wired reports 01/01/22 Amazon looks particularly attractive after wild year for tech, Barron's says MSFT Microsoft $267.85 / +8.84 (+3.41%) 06/23/22 Blizzard's 'Overwatch 2' to replace original 'Overwatch' live service, IGN says 06/23/22 Walmart reducing dependence on cloud giants with new capabilities, WSJ reports 06/22/22 Microsoft plans to do more to slow Russian propaganda, WaPo reports 06/21/22 Activision holders approve public harassment reporting proposal, WaPo says OKTA MSFT OKTA Okta $101.20 / +7.8099 (+8.36%) 06/03/22 What You Missed On Wall Street On Friday 06/03/22 What You Missed On Wall Street This Morning 06/03/22 Fly Intel: Pre-market Movers 06/02/22 Fly Intel: After-Hours Movers MSFT Microsoft $267.85 / +8.84 (+3.41%) 06/22/22 What You Missed This Week in Video Games 06/22/22 What You Missed On Wall Street This Morning 06/14/22 What You Missed This Week in Video Games 06/10/22 What You Missed On Wall Street This Morning OKTA MSFT OKTA Okta $101.20 / +7.8099 (+8.36%) 06/02/22 Okta options imply 8.8% move in share price post-earnings 03/22/22 Unusually active option classes on open March 22nd 02/18/22 Okta put volume heavy and directionally bearish 01/21/22 Okta put volume heavy and directionally bearish MSFT Microsoft $267.85 / +8.84 (+3.41%) 06/03/22 Unusually active option classes on open June 3rd 06/02/22 Unusually active option classes on open June 2nd 05/31/22 Microsoft call volume above normal and directionally bullish 05/02/22 Microsoft put buyer realizes 57% same-day gains
Hot Stocks	Capricor Therapeutics announces one-year results from HOPE-2 OLE study » 07:18 06/27/22 06/27 07:18 06/27/22 07:18 CAPR Capricor Therapeutics $4.52 / -0.03 (-0.66%) Capricor Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Options CAPR Capricor Therapeutics $4.52 / -0.03 (-0.66%) 05/25/22 Capricor Therapeutics appoints Avat as Chief Business Officer 03/28/22 Capricor Therapeutics reports results from Phase 2 INSPIRE study 03/11/22 Capricor Therapeutics publishes results from Phase 2 study of CAP-1002 03/02/22 Capricor Therapeutics appoints Paulson as VP of Clinical Development CAPR Capricor Therapeutics $4.52 / -0.03 (-0.66%) 01/31/22 H.C. Wainwright Capricor Therapeutics price target raised to $18 from $14 at H.C. Wainwright 10/11/21 H.C. Wainwright Capricor Therapeutics price target raised to $14 from $9 at H.C. Wainwright CAPR Capricor Therapeutics $4.52 / -0.03 (-0.66%) 03/10/22 Capricor Therapeutics options imply 18.1% move in share price post-earnings
Recommendations	CarMax price target raised to $105 from $90 at Wedbush » 07:16 06/27/22 06/27 07:16 06/27/22 07:16 KMX CarMax $98.44 / +6.68 (+7.28%) Wedbush analyst Seth… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options KMX CarMax $98.44 / +6.68 (+7.28%) 06/24/22 CarMax plans to open ten new locations in FY23 06/24/22 CarMax sold 427,257 units in Q1, down 5.5% from the prior year quarter 05/16/22 Tepper's Appaloosa buys two casinos in Q1, exits T-Mobile and GM 04/12/22 CarMax drops 5% to $98.05 after Q4 earnings miss estimates KMX CarMax $98.44 / +6.68 (+7.28%) 06:54 Today Baird CarMax valuation attractive for patient investors, says Baird 06/07/22 JPMorgan CarMax price target lowered to $105 from $110 at JPMorgan 05/16/22 Evercore ISI CarMax added to 'Tactical Outperform' list at Evercore ISI 05/02/22 Needham Needham starts CarMax at Hold amid increased spending on omni-channel strategy KMX CarMax $98.44 / +6.68 (+7.28%) 06/24/22 CarMax reports Q1 EPS $1.56, consensus $1.49 06/23/22 Notable companies reporting before tomorrow's open 06/23/22 Notable companies reporting before tomorrow's open 04/12/22 CarMax reports Q4 EPS 98c, consensus $1.25 KMX CarMax $98.44 / +6.68 (+7.28%) 02/26/22 Deere among quality companies doing business mostly in the U.S., Barron's says KMX CarMax $98.44 / +6.68 (+7.28%) 06/24/22 What You Missed On Wall Street On Friday 06/24/22 What You Missed On Wall Street This Morning 05/02/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/13/22 What You Missed On Wall Street On Wednesday 09/29/22 CarMax - KMX 06/28/22 CarMax Inc. KMX CarMax $98.44 / +6.68 (+7.28%) 04/12/22 Unusually active option classes on open April 12th
Hot Stocks	Frontier Group issues open letter to Spirit Airlines shareholders » 07:15 06/27/22 06/27 07:15 06/27/22 07:15 ULCC Frontier Group $10.53 / +0.655 (+6.64%) , SAVE Spirit Airlines $24.54 / +0.71 (+2.98%) Frontier Group (ULCC),… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ULCC SAVE ULCC Frontier Group $10.53 / +0.655 (+6.64%) 06/26/22 Fly Intel: Top five weekend stock stories 06/26/22 ISS recommends Spirit holders vote for amended merger agreement with Frontier 06/24/22 Spirit Airlines board says JetBlue's revised offer 'not a Superior Proposal' 06/24/22 Frontier Group raises Spirit Airlines deal consideration by $2.00 per share SAVE Spirit Airlines $24.54 / +0.71 (+2.98%) 06/26/22 Fly Intel: Top five weekend stock stories 06/26/22 ISS recommends Spirit holders vote for amended merger agreement with Frontier 06/24/22 Spirit Airlines board says JetBlue's revised offer 'not a Superior Proposal' 06/24/22 Frontier Group raises Spirit Airlines deal consideration by $2.00 per share ULCC SAVE ULCC Frontier Group $10.53 / +0.655 (+6.64%) 06/23/22 Raymond James Frontier Group upgraded to Outperform from Market Perform at Raymond James 06/10/22 JPMorgan Spirit Airlines upgraded to Overweight from Neutral at JPMorgan 04/11/22 MKM Partners JetBlue upgraded to Neutral at MKM Partners on valuation 04/06/22 MKM Partners MKM Partners expects to see 'heavy regulatory pushback' to JetBlue-Spirit deal SAVE Spirit Airlines $24.54 / +0.71 (+2.98%) 06/23/22 Raymond James Frontier Group upgraded to Outperform from Market Perform at Raymond James 06/10/22 JPMorgan Spirit Airlines upgraded to Overweight from Neutral at JPMorgan 05/05/22 Deutsche Bank Spirit Airlines price target lowered to $27 from $38 at Deutsche Bank 04/11/22 MKM Partners JetBlue upgraded to Neutral at MKM Partners on valuation ULCC SAVE ULCC Frontier Group $10.53 / +0.655 (+6.64%) 04/28/22 Frontier Group sees Q2 pre-tax margin between 1%-5% 04/28/22 Frontier Group reports Q1 EPS (56c), consensus (43c) 02/07/22 Frontier Group is not providing guidance 02/07/22 Frontier Group is not providing guidance SAVE Spirit Airlines $24.54 / +0.71 (+2.98%) 06/20/22 Fly Intel: Top five weekend stock stories 05/04/22 Spirit Airlines sees FY22 other capital expenditures $240M 05/04/22 Spirit Airlines sees Q2 adjusted operating expenses $1.355B-$1.365B 05/04/22 Spirit Airlines reports Q1 adjusted EPS ($1.60), consensus ($1.58) ULCC SAVE ULCC Frontier Group $10.53 / +0.655 (+6.64%) 04/05/22 JetBlue offers roughly $3.6B for Spirit Airlines, NY Times says SAVE Spirit Airlines $24.54 / +0.71 (+2.98%) 06/17/22 Buttigieg asks airlines to prepare for potentially busy summer, WSJ reports 06/10/22 CDC to lift negative test requirement to enter U.S., CNN reports 04/21/22 DOJ appeals transportation mask mandate ruling, NYT reports 04/20/22 CDC requests that DOJ appeal ruling to lift travel mask mandate, CNBC says ULCC SAVE ULCC Frontier Group $10.53 / +0.655 (+6.64%) 06/23/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/21/22 What You Missed On Wall Street On Tuesday 06/21/22 What You Missed On Wall Street This Morning 06/10/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations SAVE Spirit Airlines $24.54 / +0.71 (+2.98%) 06/23/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/21/22 What You Missed On Wall Street On Tuesday 06/21/22 What You Missed On Wall Street This Morning 06/21/22 Fly Intel: Pre-market Movers 06/30/22 Spirit Airlines, Inc. SAVE SAVE Spirit Airlines $24.54 / +0.71 (+2.98%) 06/24/22 Spirit Airlines call volume above normal and directionally bullish 05/16/22 Unusually active option classes on open May 16th 05/12/22 Spirit Airlines call volume above normal and directionally bullish 04/06/22 Unusually active option classes on open April 6th

Initiation	AXT Inc. initiated with a Buy at Needham » 07:15 06/27/22 06/27 07:15 06/27/22 07:15 AXTI AXT Inc. $6.22 / +0.27 (+4.54%) Needham analyst Charles… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings AXTI AXT Inc. $6.22 / +0.27 (+4.54%) 01/10/22 AXT Inc. announces formal application for subsidiary IPO on STAR Market AXTI AXT Inc. $6.22 / +0.27 (+4.54%) 04/29/22 Northland AXT Inc. price target lowered to $12 from $15 at Northland 04/29/22 B. Riley AXT Inc. price target lowered to $8 from $9.50 at B. Riley 11/04/21 Fly Intel: Top five analyst initiations 11/04/21 Wedbush AXT Inc. initiated with an Outperform at Wedbush AXTI AXT Inc. $6.22 / +0.27 (+4.54%) 04/28/22 AXT Inc. reports Q1 EPS 7c, consensus 6c 02/16/22 AXT Inc. sees FY22 revenue up 15%-20%, consensus $158.14M 02/16/22 AXT Inc. sees Q1 EPS 7c-9c, consensus 8c 02/16/22 AXT Inc. reports Q4 EPS 7c, consensus 6c
Recommendations	Xenon Pharmaceuticals price target lowered to $41 from $47 at Wedbush » 07:15 06/27/22 06/27 07:15 06/27/22 07:15 XENE Xenon Pharmaceuticals $30.97 / -0.73 (-2.30%) Wedbush analyst Laura… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events XENE Xenon Pharmaceuticals $30.97 / -0.73 (-2.30%) 06/22/22 Xenon provides update on additional data from XEN1101 program 06/21/22 Xenon Pharmaceuticals on track to initiate XEN1101 Phase 3 program in 2H22 05/03/22 Xenon Pharmaceuticals announces initiation of Phase 3 trial of XEN1101 01/19/22 Xenon Pharmaceuticals' flunarizine granted FDA orphan designation XENE Xenon Pharmaceuticals $30.97 / -0.73 (-2.30%) 11/11/21 SVB Leerink Xenon Pharmaceuticals price target raised to $40 from $34 at SVB Leerink 10/28/21 RBC Capital Xenon Pharmaceuticals initiated with an Outperform at RBC Capital 10/06/21 Wedbush Wedbush remains bullish on Xenon as financing gives firepower to advance XEN1101 10/04/21 Jefferies Jefferies ups Xenon target to $50 after 'home run' epilepsy data XENE Xenon Pharmaceuticals $30.97 / -0.73 (-2.30%) 05/10/22 Xenon Pharmaceuticals reports Q1 EPS (35c), consensus (41c) 23 Jun 06 Oct XENE Xenon Pharmaceuticals $30.97 / -0.73 (-2.30%) 06/23/22 What You Missed On Wall Street On Thursday 06/23/22 What You Missed On Wall Street This Morning 06/23/22 Fly Intel: Pre-market Movers 06/22/22 Fly Intel: After-Hours Movers 08/15/22 2022 Biotech Summer Summit
Hot Stocks	Akero Therapeutics presents analysis from Phase 2a BALANCED study » 07:13 06/27/22 06/27 07:13 06/27/22 07:13 AKRO Akero Therapeutics $10.34 / -0.36 (-3.36%) Akero Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly AKRO Akero Therapeutics $10.34 / -0.36 (-3.36%) 06/16/22 Akero Therapeutics announces two financing transactions for up to $125M 06/13/22 Akero Therapeutics to present keystone symposium on efruxifermin 05/06/22 Akero Therapeutics expects cash to fund operations into Q3 of 2023 02/25/22 Akero Therapeutics 'on track' to report HARMONY results in Q3 AKRO Akero Therapeutics $10.34 / -0.36 (-3.36%) 11/15/21 Canaccord Searching... price target raised to $49 from $46 at Canaccord 10/19/21 Fly Intel: Top five analyst downgrades 10/19/21 Morgan Stanley Akero Therapeutics assumed at Equal Weight from Overweight at Morgan Stanley 09/10/21 BofA Akero Therapeutics initiated with a Buy at BofA AKRO Akero Therapeutics $10.34 / -0.36 (-3.36%) 05/06/22 Akero Therapeutics reports Q1 EPS (74c), consensus (80c) 02/25/22 Akero Therapeutics reports Q4 EPS (93c), consensus (82c) AKRO Akero Therapeutics $10.34 / -0.36 (-3.36%) 05/08/22 Short Report: GitLab back in bears’ crosshairs 01/18/22 Fly Insider: Landec, AMC Entertainment among week's notable insider trades 12/31/21 Short Report: Krispy Kreme shorts capitulate
Hot Stocks	Aclaris Therapeutics appoints Gail Cawkwell, MD, PhD, as Chief Medical Officer » 07:13 06/27/22 06/27 07:13 06/27/22 07:13 ACRS Aclaris Therapeutics $14.41 / -1.44 (-9.09%) Aclaris… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings ACRS Aclaris Therapeutics $14.41 / -1.44 (-9.09%) 06/03/22 PDS Biotechnology appoints Brown as SVP, General Counsel 02/24/22 Aclaris Therapeutics expects cash to fund operations through end of 2024 02/01/22 Aclaris Therapeutics names James Loerop as Chief Business Officer 01/11/22 Aclaris Therapeutics falls after reporting Chief Medical Officer departed ACRS Aclaris Therapeutics $14.41 / -1.44 (-9.09%) 05/10/22 Piper Sandler Piper Sandler remains bullish on Aclaris Therapeutics after in-line Q1 update 12/07/21 Piper Sandler Piper Sandler remains bullish on Aclaris Therapeutics following R&D day 07/23/21 Jefferies Aclaris Therapeutics assumed with a Buy at Jefferies ACRS Aclaris Therapeutics $14.41 / -1.44 (-9.09%) 05/10/22 Aclaris Therapeutics reports Q1 EPS (31c), consensus (40c) 02/24/22 Aclaris Therapeutics reports Q4 EPS (37c), consensus (36c)
Recommendations	William Blair sees 'some likelihood of higher bids' for Zendesk » 07:12 06/27/22 06/27 07:12 06/27/22 07:12 ZEN Zendesk $74.05 / +16.03 (+27.63%) It is not out of the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options ZEN Zendesk $74.05 / +16.03 (+27.63%) 06/24/22 Zendesk rises 27.9% 06/24/22 Zendesk rises 29.0% 06/24/22 Zendesk rises 28.7% 06/24/22 Zendesk up 30% to $75.55 after agreeing to be acquired for $77.50 per share ZEN Zendesk $74.05 / +16.03 (+27.63%) 06/25/22 UBS Zendesk price target lowered to $77.50 from $128 at UBS 06/24/22 Stifel Stifel keeps Buy rating on Zendesk, doesn't see 'end of the road quite yet' 06/24/22 Canaccord Zendesk downgraded to Hold from Buy at Canaccord 06/24/22 Jefferies Competing Zendesk bid 'possible, but not probable,' says Jefferies ZEN Zendesk $74.05 / +16.03 (+27.63%) 04/28/22 Zendesk sees 2022 revenue $1.685B-$1.71B, consensus $1.69B 04/28/22 Zendesk sees Q2 revenue $402M-$408M, consensus $404.6M 04/28/22 Zendesk reports Q1 EPS 12c, consensus 14c 04/28/22 Notable companies reporting after market close ZEN Zendesk $74.05 / +16.03 (+27.63%) 06/23/22 Zendesk close to reaching deal with buyout firms, WSJ says 06/14/22 Zendesk in settlement discussions with Jana Partners, WSJ reports 06/08/22 Jana to sue Zendesk to set annual meeting date, Bloomberg reports 06/08/22 Zendesk buyout by PE suitors looking 'less likely,' CNBC's Faber says ZEN Zendesk $74.05 / +16.03 (+27.63%) 06/24/22 What You Missed On Wall Street On Friday 06/24/22 What You Missed On Wall Street This Morning 06/24/22 Fly Intel: Pre-market Movers 06/13/22 What You Missed On Wall Street On Monday ZEN Zendesk $74.05 / +16.03 (+27.63%) 06/24/22 Unusually active option classes on open June 24th 04/28/22 Zendesk options imply 6.2% move in share price post-earnings 04/27/22 Zendesk call volume above normal and directionally bullish 04/14/22 Zendesk call volume above normal and directionally bullish

Hot Stocks	Amryt Pharma appoints Tracy Cunningham as chief medical officer » 07:12 06/27/22 06/27 07:12 06/27/22 07:12 AMYT Amryt Pharma $7.22 / -0.11 (-1.50%) Amryt announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly AMYT Amryt Pharma $7.22 / -0.11 (-1.50%) 06/24/22 Amryt Pharma to pursue Formal Dispute Resolution for Oleogel-S10 NDA 06/23/22 Amryt Pharma announces EC approval of Filsuvez in the EU 06/13/22 Amryt Pharma presents clinical data from OLEs of Mycapssa trials 05/17/22 Amryt Pharma announces details of EMA Contingent Value Rights payment AMYT Amryt Pharma $7.22 / -0.11 (-1.50%) 03/10/22 H.C. Wainwright Amryt Pharma price target lowered to $18 from $20 at H.C. Wainwright 03/01/22 Maxim Amryt Pharma price target lowered to $18 from $27 at Maxim 03/01/22 Canaccord Amryt Pharma price target lowered to $19 from $40 at Canaccord 03/01/22 H.C. Wainwright Amryt Pharma price target lowered to $20 from $29 at H.C. Wainwright AMYT Amryt Pharma $7.22 / -0.11 (-1.50%) 05/04/22 Amryt Pharma reaffirms 2022 revenue $260M-$270M, consensus $269.26M 05/04/22 Amryt Pharma reports Q1 EPS (5c), consensus (2c) 03/09/22 Amryt Pharma sees 2022 revenue $260M-$270M, consensus $341.17M 03/09/22 Amryt Pharma reports Q4 EPS 7c, consensus (15c) AMYT Amryt Pharma $7.22 / -0.11 (-1.50%) 03/09/22 Fly Intel: Pre-market Movers
Hot Stocks	Precision BioSciences announces closing of underwritten offering of stock » 07:11 06/27/22 06/27 07:11 06/27/22 07:11 DTIL Precision BioSciences $1.47 / +0.01 (+0.68%) Precision BioSciences… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events DTIL Precision BioSciences $1.47 / +0.01 (+0.68%) 06/21/22 Precision BioSciences announces agreement with Novartis 06/08/22 Precision BioSciences provides update on allogeneic CAR T programs 05/18/22 Precision BioSciences publishes data from in vivo gene editing program 05/12/22 Precision BioSciences announces grant of inducement awards under Nasdaq rule DTIL Precision BioSciences $1.47 / +0.01 (+0.68%) 06/16/22 BMO Capital Precision BioSciences initiated with an Outperform at BMO Capital 06/09/22 William Blair Precision BioSciences downgraded to Market Perform at William Blair 12/13/21 BTIG Precision BioSciences price target raised to $20 from $16 at BTIG DTIL Precision BioSciences $1.47 / +0.01 (+0.68%) 05/09/22 Precision BioSciences reports Q1 EPS (46c), consensus (54c) 06/29/22 2022 Virtual Cell Therapy Summit
Hot Stocks	Eargo announces up to $125M strategic investment from Patient Square Capital » 07:10 06/27/22 06/27 07:10 06/27/22 07:10 EAR Eargo $1.25 / +0.07 (+5.93%) Eargo announced it has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Options EAR Eargo $1.25 / +0.07 (+5.93%) 05/31/22 Nasdaq confirms continued listing of Eargo stock 05/13/22 Eargo receives Nasdaq non-compliance letter 04/29/22 Eargo sees Q1 gross systems shipped 5,770 04/29/22 Eargo enters civil settlement agreement with U.S. DOJ EAR Eargo $1.25 / +0.07 (+5.93%) 09/23/21 Fly Intel: Top five analyst downgrades 09/23/21 William Blair William Blair downgrades Eargo on 'multiple unknowns' from criminal probe 09/23/21 Wells Fargo Wells Fargo cuts Eargo to Equal Weight, slashes price target $10 from $52 09/23/21 William Blair Eargo downgraded to Market Perform from Outperform at William Blair EAR Eargo $1.25 / +0.07 (+5.93%) 03/07/22 Eargo options imply 12.6% move in share price post-earnings 02/10/22 Eargo options imply 10.7% move in share price post-earnings 02/03/22 Eargo options imply 9.5% move in share price post-earnings 01/27/22 Eargo options imply 14.5% move in share price post-earnings
Initiation	Liquidity Services initiated with a Buy at Craig-Hallum » 07:10 06/27/22 06/27 07:10 06/27/22 07:10 LQDT Liquidity Services $13.98 / -0.07 (-0.50%) Craig-Hallum analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research LQDT Liquidity Services $13.98 / -0.07 (-0.50%) 06/06/22 Liquidity Services selected to sell two offshore oil, gas helicopters 05/26/22 Liquidity Services selected to auction assets of major oil pipeline project 05/25/22 Metra selling prime acreage in Crystal Lake, IL on GovDeals 04/29/22 California school district partners with GovDeals to sell Myrtha Pool LQDT Liquidity Services $13.98 / -0.07 (-0.50%) 05/09/22 Barrington Liquidity Services target lowered to $26 at Barrington on adjusted EBITDA view
Recommendations	Micron price target lowered to $85 from $115 at BMO Capital » 07:10 06/27/22 06/27 07:10 06/27/22 07:10 MU Micron $58.48 / +2.23 (+3.96%) BMO Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MU Micron $58.48 / +2.23 (+3.96%) 05/30/22 Fly Intel: Top five weekend stock stories 05/16/22 Tepper's Appaloosa buys two casinos in Q1, exits T-Mobile and GM 05/12/22 Micron CEO: Our end markets are well diversified 05/12/22 Micron to raise dividend to 11.5c from 10c per share MU Micron $58.48 / +2.23 (+3.96%) 06/21/22 Morgan Stanley Micron price target lowered to $56 from $83 at Morgan Stanley 06/21/22 Mizuho Micron price target lowered to $95 from $113 at Mizuho 06/13/22 Deutsche Bank Micron shares already price in estimate cut, says Deutsche Bank 06/13/22 UBS Micron price target lowered to $115 from $120 at UBS MU Micron $58.48 / +2.23 (+3.96%) 03/29/22 Micron sees Q3 EPS of $2.46, plus or minus 10c, consensus $2.21 03/29/22 Micron reports Q2 EPS $2.14, consensus $1.97 03/29/22 Notable companies reporting after market close MU Micron $58.48 / +2.23 (+3.96%) 06/13/22 Micron to commercialize 1-gamma EUV process in Taiwan in 2024, DigiTimes says 05/28/22 Alphabet, Meta among bargain stocks to buy now, Barron's says 05/14/22 Western Digital, Micron look 'impossibly' cheap, Barron's says 04/02/22 Micron trades like a commodity, stock deserves better, Barron's says MU Micron $58.48 / +2.23 (+3.96%) 06/13/22 What You Missed On Wall Street On Monday 06/13/22 What You Missed On Wall Street This Morning 06/03/22 What You Missed On Wall Street On Friday 06/03/22 What You Missed On Wall Street This Morning 06/30/22 Micron - MU MU Micron $58.48 / +2.23 (+3.96%) 06/03/22 Unusually active option classes on open June 3rd 05/09/22 Micron call volume above normal and directionally bullish 04/20/22 Early notable gainers among liquid option names on April 20th 03/31/22 Notable open interest changes for March 31st

Hot Stocks	Canada Nickel announces assay results and confirms discovery at Reid Property » 07:10 06/27/22 06/27 07:10 06/27/22 07:10 CNIKF Canada Nickel $1.24 / +0.13 (+11.71%) Canada Nickel Company … Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research CNIKF Canada Nickel $1.24 / +0.13 (+11.71%) 06/07/22 Canada Nickel, Grid Metals announce sale of Bannockburn Nickel Property CNIKF Canada Nickel $1.24 / +0.13 (+11.71%) 08/17/21 Roth Capital Canada Nickel initiated with a Buy at Roth Capital
Hot Stocks	Origin Materials joins Russell 2000, Russell 3000 Indexes » 07:09 06/27/22 06/27 07:09 06/27/22 07:09 ORGN Origin Materials $5.25 / -0.195 (-3.58%) Origin Materials will… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ORGN Origin Materials $5.25 / -0.195 (-3.58%) 06/16/22 Origin Materials, Kuraray announce carbon negative materials partnership 06/02/22 Origin Materials gets USDA Certified Biobased Product label for more products 05/09/22 Origin Materials sees FY22 adjusted EBITDA loss up to ($36M) 05/09/22 Origin Materials: Origin 1 construction timeline 'on track' ORGN Origin Materials $5.25 / -0.195 (-3.58%) 01/06/22 BofA Origin Materials upgraded to Buy at BofA ahead of improved valuations 01/06/22 BofA Origin Materials upgraded to Buy from Neutral at BofA 11/23/21 HSBC Origin Materials initiated with a Buy at HSBC 10/05/21 BofA Origin Materials initiated with a Neutral at BofA ORGN Origin Materials $5.25 / -0.195 (-3.58%) 05/09/22 Origin Materials reports Q1 EPS 5c, consensus (6c) 02/24/22 Origin Materials reports Q4 EPS 4c, consensus (6c) 11:00 Today Origin Materials Inc. 07/20/22 Origin Materials
Recommendations	Carnival bull-bear debate unsettled with Q2 report, says Deutsche Bank » 07:08 06/27/22 06/27 07:08 06/27/22 07:08 CCL Carnival $10.87 / +1.22 (+12.65%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CCL Carnival $10.87 / +1.22 (+12.65%) 06/24/22 Carnival Cruise Line brand to reach nearly 110% occupancy in Q3, says CEO 06/24/22 Carnival CEO says 'aggressively, yet thoughtfully ramping up to full operations' 06/24/22 Carnival reports Q2 occupancy 69%, up from 54% in Q1 06/24/22 Carnival provides update on bookings CCL Carnival $10.87 / +1.22 (+12.65%) 06:52 Today Stifel Stifel still sees value in Carnival despite 'drastically' cutting estimates 06:47 Today Wells Fargo Carnival price target lowered to $13 from $21 at Wells Fargo 06/21/22 Deutsche Bank Carnival price target lowered to $14 from $24 at Deutsche Bank 06/14/22 HSBC Carnival price target lowered to $7.70 from $18.20 at HSBC CCL Carnival $10.87 / +1.22 (+12.65%) 06/24/22 Carnival expects a net loss for Q3 06/24/22 Carnival reports Q2 EPS ($1.61), consensus ($1.08) 06/23/22 Notable companies reporting before tomorrow's open 06/23/22 Notable companies reporting before tomorrow's open CCL Carnival $10.87 / +1.22 (+12.65%) 06/13/22 Carnival CEO tells Bloomberg company is 'recession resilient' 05/24/22 Carnival in talks to sell Seabourn to Saudi fund, CNBC's Mody reports 03/02/22 Carnival, Norwegian update mask policy, now optional for most, WSJ reports 01/07/22 Royal Caribbean, Norwegian Cruise cancel trips due to omicron, Reuters reports CCL Carnival $10.87 / +1.22 (+12.65%) 06/24/22 What You Missed On Wall Street On Friday 06/24/22 What You Missed On Wall Street This Morning 06/17/22 Bet On It: Maryland governor calls for online sports betting timeline 05/24/22 What You Missed On Wall Street On Tuesday CCL Carnival $10.87 / +1.22 (+12.65%) 06/24/22 Early notable gainers among liquid option names on June 24th 05/26/22 Notable open interest changes for May 26th 05/25/22 Unusually active option classes on open May 25th 05/25/22 Notable open interest changes for May 25th
Hot Stocks	ADMA Biologics receives FDA approval for sixth plasma collection center » 07:08 06/27/22 06/27 07:08 06/27/22 07:08 ADMA ADMA Biologics $1.91 / -0.165 (-7.95%) ADMA Biologics announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate ADMA ADMA Biologics $1.91 / -0.165 (-7.95%) 06/21/22 ADMA Biologics announces addition to Russell 2000 Index 03/25/22 ADMA announces FDA approval of extended shelf life for ASCENIV, BIVIGAM 03/07/22 ADMA Biologics receives FDA approval for fifth ADMA BioCenters plasma collection 01/19/22 ADMA Biologics says strategic review is ongoing ADMA ADMA Biologics $1.91 / -0.165 (-7.95%) 11/11/21 Raymond James ADMA Biologics upgraded to Strong Buy from Outperform at Raymond James 11/08/21 Cantor Fitzgerald Cantor starts ADMA Biologics at Overweight with $4.50 price target 11/08/21 Cantor Fitzgerald ADMA Biologics initiated with an Overweight at Cantor Fitzgerald 07/06/21 H.C. Wainwright ADMA Biologics price target lowered to $7 from $10 at H.C. Wainwright ADMA ADMA Biologics $1.91 / -0.165 (-7.95%) 03/24/22 ADMA Biologics reports Q4 EPS (9c), consensus (9c) 01/19/22 ADMA Biologics sees Q4 revenue $26M, consensus $21.76M 21 Oct
Hot Stocks	EVgo added to Russell 3000, Russell 2000 Indexes » 07:08 06/27/22 06/27 07:08 06/27/22 07:08 EVGO EVgo $7.65 / -0.45 (-5.56%) EVgo has been added to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options EVGO EVgo $7.65 / -0.45 (-5.56%) 07:08 Today EVgo, General Motors activate Plug and Charge across EVgo network 06/22/22 EVgo selected for $3.6M in grant funding from California Energy Commission 05/10/22 EVgo selected as EV charging network provider for Portland, Maine 04/25/22 EVgo opens new EVgo public fast charging station in Maryland EVGO EVgo $7.65 / -0.45 (-5.56%) 06/08/22 Capital One EVgo upgraded to Overweight from Equalweight at Capital One 05/16/22 Citi EVgo price target lowered to $10 from $11 at Citi 05/12/22 Credit Suisse Credit Suisse upgrades EVgo to Outperform with $14 price target 05/12/22 Credit Suisse EVgo upgraded to Outperform from Neutral at Credit Suisse EVGO EVgo $7.65 / -0.45 (-5.56%) 05/11/22 EVgo sees 2022 revenue $48M-$55M, consensus $51.18M 05/11/22 EVgo reports Q1 EPS (21c), consensus (14c) 03/23/22 EVgo reports Q4Adj. EBITDA ($16.3M) vs. ($14.3M) in Q3 EVGO EVgo $7.65 / -0.45 (-5.56%) 06/25/22 Short Report: Bears undeterred by bounce in growth names 06/08/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/16/22 What You Missed This Week in EVs and Clean Energy 05/12/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations EVGO EVgo $7.65 / -0.45 (-5.56%) 06/23/22 Largest borrow rate increases among liquid names 05/18/22 Largest borrow rate increases among liquid names 04/22/22 EVgo put volume heavy and directionally bearish 04/19/22 Largest borrow rate increases among liquid names

Hot Stocks	EVgo, General Motors activate Plug and Charge across EVgo network » 07:08 06/27/22 06/27 07:08 06/27/22 07:08 EVGO EVgo $7.65 / -0.45 (-5.56%) , GM General Motors $34.83 / +1.845 (+5.59%) EVgo Inc. (EVGO) and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options EVGO GM EVGO EVgo $7.65 / -0.45 (-5.56%) 06/22/22 EVgo selected for $3.6M in grant funding from California Energy Commission 05/10/22 EVgo selected as EV charging network provider for Portland, Maine 04/25/22 EVgo opens new EVgo public fast charging station in Maryland 04/18/22 EVgo teases partnership with Mullen Automotive in tweet GM General Motors $34.83 / +1.845 (+5.59%) 06/26/22 Fly Intel: Top five weekend stock stories 06/21/22 FedEx receives first 150 electric delivery vehicles from General Motors startup 06/16/22 EU passenger car registrations down 11.2% in May 06/15/22 General Motors to invest $81M to prepare to build Cadillac CELESTIQ EVGO GM EVGO EVgo $7.65 / -0.45 (-5.56%) 06/08/22 Capital One EVgo upgraded to Overweight from Equalweight at Capital One 05/16/22 Citi EVgo price target lowered to $10 from $11 at Citi 05/12/22 Credit Suisse Credit Suisse upgrades EVgo to Outperform with $14 price target 05/12/22 Credit Suisse EVgo upgraded to Outperform from Neutral at Credit Suisse GM General Motors $34.83 / +1.845 (+5.59%) 06/16/22 Goldman Sachs Goldman left Samsara analyst day with stronger conviction 06/07/22 Morgan Stanley MP Materials price target raised to $46 from $42 at Morgan Stanley 06/01/22 Goldman Sachs General Motors price target lowered to $46 from $59 at Goldman Sachs 06/01/22 Citi General Motors price target lowered to $87 from $98 at Citi EVGO GM EVGO EVgo $7.65 / -0.45 (-5.56%) 05/11/22 EVgo sees 2022 revenue $48M-$55M, consensus $51.18M 05/11/22 EVgo reports Q1 EPS (21c), consensus (14c) 03/23/22 EVgo reports Q4Adj. EBITDA ($16.3M) vs. ($14.3M) in Q3 GM General Motors $34.83 / +1.845 (+5.59%) 04/26/22 General Motors sees FY22 adjusted EPS $6.50-$7.50, consensus $6.70 04/26/22 General Motors reports Q1 adjusted EPS $2.09, consensus $1.68 04/26/22 Notable companies reporting after market close 02/01/22 General Motors sees FY22 adjusted EPS $6.25-$7.25, consensus $6.92 GM GM General Motors $34.83 / +1.845 (+5.59%) 06/26/22 Tesla. Ford and GM raise EV prices as costs and demand grow, WSJ reports 06/25/22 GM stock looking like a bargain after begin hammered, Barron's says 06/23/22 Cruise officially charging for driverless rides in San Francisco, Verge reports 06/23/22 GM to add 'Plug and Charge' capability to its EVs, TechCrunch reports EVGO GM EVGO EVgo $7.65 / -0.45 (-5.56%) 06/25/22 Short Report: Bears undeterred by bounce in growth names 06/08/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/16/22 What You Missed This Week in EVs and Clean Energy 05/12/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations GM General Motors $34.83 / +1.845 (+5.59%) 06/21/22 What You Missed This Week in EVs and Clean Energy 06/13/22 What You Missed This Week in EVs and Clean Energy 06/03/22 What You Missed On Wall Street On Friday 06/03/22 What You Missed On Wall Street This Morning EVGO GM EVGO EVgo $7.65 / -0.45 (-5.56%) 06/23/22 Largest borrow rate increases among liquid names 05/18/22 Largest borrow rate increases among liquid names 04/22/22 EVgo put volume heavy and directionally bearish 04/19/22 Largest borrow rate increases among liquid names GM General Motors $34.83 / +1.845 (+5.59%) 06/16/22 General Motors call volume above normal and directionally bullish 06/16/22 Unusually active option classes on open June 16th 05/12/22 Unusually active option classes on open May 12th 05/02/22 Unusually active option classes on open May 2nd
Hot Stocks	Flex, Ceva announce silicon implementation using eFPGA » 07:08 06/27/22 06/27 07:08 06/27/22 07:08 FLEX Flex $15.36 / +0.77 (+5.28%) , CEVA Ceva $34.40 / +0.955 (+2.86%) Flex Logix Technologies… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options FLEX CEVA FLEX Flex $15.36 / +0.77 (+5.28%) 06/14/22 Flex to expand automotive industry operations in Jalisco, Mexico 02/02/22 Flex to sell $500M of convertible preferred equity in Nextracker to TPG Rise 01/26/22 Flex jumps 6% to $16.76 after Q3 results, FY22 guidance top estimates CEVA Ceva $34.40 / +0.955 (+2.86%) 03/29/22 Ceva, STMicroelectronics, Wacom collaborate to enhance digital pens 02/28/22 Ceva extends Wi-Fi portfolio with Wi-Fi 6/6E IP 01/05/22 Winner Micro licenses CEVA's bluetooth and Wi-Fi IP platforms FLEX CEVA FLEX Flex $15.36 / +0.77 (+5.28%) 06/01/22 Goldman Sachs Flex price target lowered to $21 from $24 at Goldman Sachs 05/18/22 Argus Flex upgraded to Buy from Hold at Argus 05/18/22 Argus Flex upgraded to Buy from Hold at Argus 01/27/22 Craig-Hallum Flex price target lowered to $25 from $31 at Craig-Hallum CEVA Ceva $34.40 / +0.955 (+2.86%) 02/16/22 Rosenblatt Ceva upgraded to Buy from Neutral at Rosenblatt FLEX CEVA FLEX Flex $15.36 / +0.77 (+5.28%) 05/04/22 Flex sees FY23 adjusted EPS $2.09-$2.24, consensus $1.94 05/04/22 Flex sees Q1 adjusted EPS 44c-50c, consensus 43c 05/04/22 Flex reports Q4 adjusted EPS 52c, consensus 42c 03/30/22 Flex still sees FY22 adjusted EPS $1.85-$1.90, consensus $1.72 CEVA Ceva $34.40 / +0.955 (+2.86%) 05/10/22 Ceva reports Q1 non-GAAP EPS 18c, consensus 17c 02/15/22 Ceva reports Q4 non-GAAP EPS 22c, consensus 19c FLEX FLEX Flex $15.36 / +0.77 (+5.28%) 03/31/22 What You Missed On Wall Street This Morning 03/30/22 Fly Intel: After-Hours Movers 02/03/22 Wall Street in Fives - Must Read Lists for Thursday 02/03/22 Wall Street in Fives - Must Read Lists at Midday FLEX FLEX Flex $15.36 / +0.77 (+5.28%) 02/24/22 Flex put volume heavy and directionally bearish
Hot Stocks	Tonix Pharmaceuticals announces trial design of new TNX-1300 Phase 2 study » 07:07 06/27/22 06/27 07:07 06/27/22 07:07 TNXP Tonix Pharmaceuticals $1.88 / -0.12 (-6.00%) Tonix Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings TNXP Tonix Pharmaceuticals $1.88 / -0.12 (-6.00%) 06/22/22 Tonix Pharmaceuticals announces pricing of $30M private placement 06/21/22 Tonix announces publication of paper on effects of magnesium 06/16/22 Tonix announces ribbon cutting ceremony for facility in Massachusetts 06/09/22 Tonix announces data on TNX-1500 organ transplant candidate at ATC TNXP Tonix Pharmaceuticals $1.88 / -0.12 (-6.00%) 05/24/22 Noble Capital Monkeypox cases could attract attention to Tonix programs, says Noble Capital 04/18/22 Noble Capital Tonix Pharmaceuticals initiated with an Outperform at Noble Capital 08/31/21 Alliance Global Partners Alliance Global Partners ups Tonix target to $3 amid NIH interest in Long-COVID 08/11/21 Alliance Global Partners Tonix Pharmaceuticals price target lowered to $2 from $4 at Alliance Global Partners TNXP Tonix Pharmaceuticals $1.88 / -0.12 (-6.00%) 05/09/22 Tonix Pharmaceuticals reports Q1 EPS (5c), consensus (5c) 03/14/22 Tonix Pharmaceuticals reports Q4 EPS (7c), two est. (6c)
Downgrade	Descartes Systems downgraded to Neutral from Outperformer at CIBC » 07:06 06/27/22 06/27 07:06 06/27/22 07:06 DSGX Descartes Systems $65.74 / +1.8 (+2.82%) CIBC analyst Stephanie… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings DSGX Descartes Systems $65.74 / +1.8 (+2.82%) 06/06/22 Descartes Systems acquires XPS Technologies for upfront consideration of $65M 04/21/22 Descartes Systems acquires Foxtrot for $4M 02/10/22 Descartes Systems announces it has acquired NetCHB for $40M 02/07/22 Descartes' route planning solution selected by Atlantic Tire Distributors DSGX Descartes Systems $65.74 / +1.8 (+2.82%) 06/03/22 Barclays Descartes Systems price target raised to $62 from $61 at Barclays 06/02/22 BMO Capital Descartes Systems price target lowered to $68 from $81 at BMO Capital 06/02/22 Canaccord Descartes Systems price target lowered to $74 from $85 at Canaccord 05/27/22 RBC Capital Descartes Systems price target lowered to $85 from $100 at RBC Capital DSGX Descartes Systems $65.74 / +1.8 (+2.82%) 06/01/22 Descartes Systems reports Q1 EPS 27c, consensus 27c 03/02/22 Descartes Systems reports Q4 EPS 22c, consensus 27c
Hot Stocks	Zentalis names Andrea Paul as general counsel, corporate secretary » 07:06 06/27/22 06/27 07:06 06/27/22 07:06 ZNTL Zentalis $28.29 / +0.98 (+3.59%) Zentalis Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly ZNTL Zentalis $28.29 / +0.98 (+3.59%) 05/31/22 Zentalis promotes cofounder Cam Gallagher to President 05/16/22 Zentalis announces pricing of underwritten offering of common stock 05/16/22 Zentalis appoints Blackwell as Chief Executive Officer 05/05/22 Zentalis expects cash to fund requirements into 1Q24 ZNTL Zentalis $28.29 / +0.98 (+3.59%) 04/13/22 Guggenheim Zentalis price target lowered to $67 from $92 at Guggenheim 04/12/22 Piper Sandler Schrodinger has 'potent and highly selective' molecule , says Piper Sandler 04/12/22 Oppenheimer Zentalis price target lowered to $85 from $100 at Oppenheimer 04/11/22 Stifel Zentalis price target lowered to $74 from $94 at Stifel ZNTL Zentalis $28.29 / +0.98 (+3.59%) 05/05/22 Zentalis reports Q1 EPS ($1.31), consensus ($1.21) 02/24/22 Zentalis reports Q4 EPS ($1.11), consensus ($1.48) 16 May 29 Jun ZNTL Zentalis $28.29 / +0.98 (+3.59%) 04/27/22 What You Missed On Wall Street On Wednesday 04/27/22 What You Missed On Wall Street This Morning 04/06/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations

Events

Earnings calls, analyst events, roadshows and more

RLAY
Today at 08:00

Relay Therapeutics Firm Sponsored Meetings

Virtual Meeting
THO
Today at 09:00

Thor Industries Firm Sponsored Meetings

Airstream Headquarters, Jackson Center, OH
Today at 09:00

Technology/EV Supply Chain Industry Meetings
QRTEA
Today at 09:30

Qurate Retail Firm Sponsored Meetings

Virtual Meeting
NPSNY
Today at 10:00

Naspers - NPSNY Conference Calls
Today at 10:00

Consumer Industry Meetings
UTHR
Today at 10:30

United Therapeutics Corporation Firm Sponsored Meetings
DELL
Today at 10:30

Dell Technologies Inc. CL C Firm Sponsored Meetings
ORGN
Today at 11:00

Origin Materials Inc. Firm Sponsored Meetings
NTAP
Today at 11:30

NetApp - NTAP Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	IE X IE Ivanhoe Electric IPO Managers: BMO Capital & Jefferies, JPMorgan, Raymond James, RBC Capital, Scotiabank $11.75-12.50 14.388M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TUYA X TUYA Tuya Secondary Managers: CICC, BofA, Morgan Stanley & CMBI $2.30 7.3M Shares
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Hilton sees Q2 adjusted EPS 98c-$1.03, consensus $1.07

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access